<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A previously healthy 47-year-old woman was treated for follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, grade III, with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, adriamycin, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, <z:chebi fb="0" ids="8382">prednisone</z:chebi> with rituximab (CHOP-R) followed by ibritumomab tiuxetan and rituximab </plain></SENT>
<SENT sid="1" pm="."><plain>She developed a <z:e sem="disease" ids="C0036830" disease_type="Disease or Syndrome" abbrv="">serum sickness</z:e>-like illness during immunotherapy with <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0003326'>myalgias</z:hpo>, <z:hpo ids='HP_0002829'>arthralgias</z:hpo>, and pleural and <z:hpo ids='HP_0001698'>pericardial effusions</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Despite anti-inflammatory therapies her symptoms persisted for 10 months before ultimate resolution </plain></SENT>
<SENT sid="3" pm="."><plain>Her clinical course and literature are reviewed </plain></SENT>
</text></document>